Schedule 13D ownership disclosure
INOTEK PHARMACEUTICALS CORP
Security class unavailable · CUSIP: 45780V102
Event date: 2017-01-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,519,647
- Percent of class
- 5.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-17-008204
- Form type
- SC 13D
- Filer
- Care Capital III LLC
- CIK
- CIK 1599356
- Filed
- Feb 10, 2017
- Reporting period
- Jan 30, 2017
- Description
- Schedule 13D beneficial ownership